Filter News
Area of Research
- (-) Computer Science (3)
- (-) Nuclear Science and Technology (2)
- Advanced Manufacturing (2)
- Biology and Environment (10)
- Clean Energy (17)
- Computational Engineering (1)
- Fusion and Fission (2)
- Isotopes (2)
- Materials (21)
- Materials for Computing (3)
- National Security (13)
- Neutron Science (11)
- Quantum information Science (1)
- Sensors and Controls (1)
- Supercomputing (40)
News Topics
- (-) Artificial Intelligence (1)
- (-) Biomedical (1)
- (-) Computer Science (3)
- 3-D Printing/Advanced Manufacturing (2)
- Advanced Reactors (2)
- Bioenergy (1)
- Cybersecurity (1)
- Decarbonization (1)
- Energy Storage (1)
- Fusion (1)
- Isotopes (2)
- Materials Science (2)
- Neutron Science (1)
- Nuclear Energy (7)
- Physics (1)
- Quantum Science (2)
- Space Exploration (2)
- Sustainable Energy (1)
- Transformational Challenge Reactor (1)
Media Contacts
ORNL is home to the world's fastest exascale supercomputer, Frontier, which was built in part to facilitate energy-efficient and scalable AI-based algorithms and simulations.
Using complementary computing calculations and neutron scattering techniques, researchers from the Department of Energy’s Oak Ridge and Lawrence Berkeley national laboratories and the University of California, Berkeley, discovered the existence of an elusive type of spin dynamics in a quantum mechanical system.
Three researchers at Oak Ridge National Laboratory will lead or participate in collaborative research projects aimed at harnessing the power of quantum mechanics to advance a range of technologies including computing, fiber optics and network
The Department of Energy’s Oak Ridge National Laboratory is collaborating with industry on six new projects focused on advancing commercial nuclear energy technologies that offer potential improvements to current nuclear reactors and move new reactor designs closer to deployment.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.